CLPBF
Price
$96.80
Change
+$0.20 (+0.21%)
Updated
Aug 29 closing price
Capitalization
21.72B
ESLOY
Price
$152.42
Change
+$0.20 (+0.13%)
Updated
Sep 5 closing price
Capitalization
139.91B
40 days until earnings call
Interact to see
Advertisement

CLPBF vs ESLOY

Header iconCLPBF vs ESLOY Comparison
Open Charts CLPBF vs ESLOYBanner chart's image
Coloplast AS
Price$96.80
Change+$0.20 (+0.21%)
Volume$1
Capitalization21.72B
EssilorLuxottica
Price$152.42
Change+$0.20 (+0.13%)
Volume$30.31K
Capitalization139.91B
CLPBF vs ESLOY Comparison Chart in %
Loading...
CLPBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPBF vs. ESLOY commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPBF is a Hold and ESLOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CLPBF: $96.80 vs. ESLOY: $152.42)
Brand notoriety: CLPBF and ESLOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CLPBF: 0% vs. ESLOY: 31%
Market capitalization -- CLPBF: $21.72B vs. ESLOY: $139.91B
CLPBF [@Pharmaceuticals: Other] is valued at $21.72B. ESLOY’s [@Pharmaceuticals: Other] market capitalization is $139.91B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPBF’s FA Score shows that 1 FA rating(s) are green whileESLOY’s FA Score has 3 green FA rating(s).

  • CLPBF’s FA Score: 1 green, 4 red.
  • ESLOY’s FA Score: 3 green, 2 red.
According to our system of comparison, ESLOY is a better buy in the long-term than CLPBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPBF’s TA Score shows that 5 TA indicator(s) are bullish while ESLOY’s TA Score has 3 bullish TA indicator(s).

  • CLPBF’s TA Score: 5 bullish, 4 bearish.
  • ESLOY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CLPBF is a better buy in the short-term than ESLOY.

Price Growth

CLPBF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while ESLOY (@Pharmaceuticals: Other) price change was -0.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

ESLOY is expected to report earnings on Oct 16, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOY($140B) has a higher market cap than CLPBF($21.7B). ESLOY has higher P/E ratio than CLPBF: ESLOY (50.82) vs CLPBF (34.26). ESLOY YTD gains are higher at: 30.529 vs. CLPBF (-10.603). CLPBF has higher annual earnings (EBITDA): 8.66B vs. ESLOY (6.71B). ESLOY has more cash in the bank: 3.16B vs. CLPBF (729M). ESLOY has less debt than CLPBF: ESLOY (14B) vs CLPBF (24.3B). CLPBF (27.8B) and ESLOY (27.2B) have equivalent revenues.
CLPBFESLOYCLPBF / ESLOY
Capitalization21.7B140B16%
EBITDA8.66B6.71B129%
Gain YTD-10.60330.529-35%
P/E Ratio34.2650.8267%
Revenue27.8B27.2B102%
Total Cash729M3.16B23%
Total Debt24.3B14B174%
FUNDAMENTALS RATINGS
CLPBF vs ESLOY: Fundamental Ratings
CLPBF
ESLOY
OUTLOOK RATING
1..100
2672
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
10015
SMR RATING
1..100
3595
PRICE GROWTH RATING
1..100
6049
P/E GROWTH RATING
1..100
7130
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPBF's Valuation (18) in the null industry is in the same range as ESLOY (33). This means that CLPBF’s stock grew similarly to ESLOY’s over the last 12 months.

ESLOY's Profit vs Risk Rating (15) in the null industry is significantly better than the same rating for CLPBF (100). This means that ESLOY’s stock grew significantly faster than CLPBF’s over the last 12 months.

CLPBF's SMR Rating (35) in the null industry is somewhat better than the same rating for ESLOY (95). This means that CLPBF’s stock grew somewhat faster than ESLOY’s over the last 12 months.

ESLOY's Price Growth Rating (49) in the null industry is in the same range as CLPBF (60). This means that ESLOY’s stock grew similarly to CLPBF’s over the last 12 months.

ESLOY's P/E Growth Rating (30) in the null industry is somewhat better than the same rating for CLPBF (71). This means that ESLOY’s stock grew somewhat faster than CLPBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPBFESLOY
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
43%
MACD
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bearish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 9 days ago
51%
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
40%
Aroon
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
CLPBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRHC6.610.71
+12.03%
La Rosa Holdings Corp
ARVN7.830.22
+2.89%
Arvinas
THC196.183.66
+1.90%
Tenet Healthcare Corp
RSSS3.320.02
+0.70%
Research Solutions
UE21.200.10
+0.47%
Urban Edge Properties

CLPBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBF has been loosely correlated with CLPBY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBF jumps, then CLPBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBF
1D Price
Change %
CLPBF100%
N/A
CLPBY - CLPBF
38%
Loosely correlated
+2.59%
AHICF - CLPBF
26%
Poorly correlated
N/A
WILLF - CLPBF
22%
Poorly correlated
N/A
QDEL - CLPBF
20%
Poorly correlated
+3.20%
ESLOY - CLPBF
20%
Poorly correlated
+0.13%
More

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
+0.13%
ESLOF - ESLOY
58%
Loosely correlated
-2.34%
QGEN - ESLOY
43%
Loosely correlated
+1.08%
ALC - ESLOY
38%
Loosely correlated
+1.60%
SMMNY - ESLOY
38%
Loosely correlated
+0.80%
CRL - ESLOY
35%
Loosely correlated
+1.04%
More